Role of the endothelin axis in the proliferation of human thyroid cancer cells

Clinical Endocrinology

Volumn 67, Issue 4, 2007, Pages 552-556

  Donckier, Julian E ^a,b   Mertens Strijthagen, Jeannine ^a   Flamion, Bruno ^a  

^a UNIVERSITY OF NAMUR   (Belgium)

^b UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ATRASENTAN; BROXURIDINE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; MESSENGER RNA; THYMIDINE;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CANCER; THYROID FOLLICLE CELL; WESTERN BLOTTING;

ADENOCARCINOMA, FOLLICULAR; ASPARTIC ENDOPEPTIDASES; BLOTTING, WESTERN; BROMODEOXYURIDINE; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CELL PROLIFERATION; ENDOTHELIN-1; HUMANS; IMMUNORADIOMETRIC ASSAY; METALLOENDOPEPTIDASES; PYRROLIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYMIDINE; THYROID NEOPLASMS;

EID: 34548673766     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02923.x     Document Type: Article

References (22)

1. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Yasaki, Y., Goto, K. Masaki, T. (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature (London), 332, 411 415.
2. Donckier, J., Hanet, Berbinschi, A., Galanti, L., Robert, A., Van Mechelen, H., Pouleur, H. Ketelslegers, J.M. (1991) Cardiovascular and endocrine effects of endothelin-1 at pathophysiological and pharmacological plasma concentrations in conscious dogs. Circulation, 84, 2476 2484.
3. Mazaki, T. (1993) Endothelins: homeostatic and compensatory actions in the circulatory and endocrine systems. Endocrine Reviews, 14, 256 268.
4. Komuro, I., Kurihara, H., Sugiyama, T., Takaku, F. Yasaki, Y. (1998) Endothelin stimulates C-fos and C-myc expression and proliferation of vascular smooth muscle cells. FEBS Letters, 238, 249 259.
5. Galié, N., Manes, A. Branzi, A. (2004) The endothelin system in pulmonary hypertension. Cardiovascular Research, 61, 227 237.
6. Donckier, J., Stoleru, L., Hayashida, W., Van Mechelen, H., Selvais, P., Galanti, L., Clozel, J.P., Ketelslegers, J.M. Pouleur, H. (1995) Role of endogenous endothelin-1 in experimental renal hypertension in dogs. Circulation, 92, 106 113.
7. Nelson, J., Bagnato, Battistini, B. Nisen, P. (2003) The endothelin axis: emerging role in cancer. Nature Reviews, 3, 110 116.
8. Grant, K., Loizidou, M. Taylor, I. (2003) Endothelin-1: a multifunctional molecule in cancer. British Journal of Cancer, 88, 163 166.
9. Nelson, J.B., Chan-Tack, K., Hedican, S.P., Magnuson, S., Opgeworthe, T.J. Bora, G. (1996) Endothelin-1 production and decreased endothelin B receptor in advanced prostate cancer. Cancer Research, 56, 663 668.
10. Godara, G., Cannon, G.W., Cannon, G.M. Jr., Bies, R.R., Nelson, J.B. Pflug, B.R. (2005) Role of endothelin axis in progression to aggressive phenotype of prostate adenocarcinoma. The Prostate, 65, 27 34.
11. Bagnato, A., Salani, D., Di Castro, V., Wu-Wong, J.R., Tecce, R., Nicotra, M.R., Venuti, A. Natali, P.G. (1999) Expression of endothelin-1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumour growth. Cancer Research, 59, 720 727.
12. Rosano, L., Spinella, F., Salani, D., Di Castro, V., Venuti, A., Nicotra, M.R., Natali, P.G. Bagnato, A. (2003) Therapeutic targeting of endothelin A receptor in ovarian carcinoma. Cancer Research, 63, 2447 2453.
13. A in human papillary thyroid carcinoma. Clinical Endocrinology, 59, 354 360.
14. Van Beneden, R., Michel, L., Havaux, X., Delos, M. Donckier, J. (2004) Increased expression of endothelin-1 converting enzyme in human thyroid carcinoma. Clinical Endocrinology, 60, 146 147.
15. Donckier, J., Michel, L., Delos, M., Van Beneden, R. Havaux, X. (2004) Endothelin axis expression in medullary thyroid carcinoma: a potential therapeutic target. Clinical Endocrinology, 61, 280 284.
16. Donckier, J.E., Michel, L., Delos, M., Havaux, X. Van Beneden, R. (2006) Interrelated overexpression of endothelial and inducible nitric oxide synthases, endothelin-1 and angiogenic factors in human papillary thyroid carcinoma. Clinical Endocrinology, 64, 703 710.
17. Bagnato, A., Venuti, A., Di Castro, V. Marcante, M.L. (1995) Identification of the ETA receptor subtype that mediates endothelin induced autocrine proliferation of normal human keratinocytes. Biochemical and Biophysical Research Communications, 209, 80 86.
18. Lahav, R., Suva, M.-L., Rimoldi, D., Patterson, P.H. Stamenkovic, I. (2004) Endothelin receptor B inhibition triggers apoptosis and enhances angiogenesis in melanomas. Cancer Research, 64, 8945 8953.
19. Peduto Eberl, L., Bovey, R. Juillerat-Jeanneret, L. (2003) Endothelin-receptor antagonists are proaptototic and antiproliferative in human colon cancer cells. British Journal of Cancer, 88, 788 795.
20. Carducci, M.A., Padley, R.J., Breul, J., Vogelzang, N.J., Zonnenberg, B.A., Daliani, D.D., Schulman, C.C., Nabulsi, A.A., Humerickhouse, R.A., Weinberg, M.A., Schmitt, J.L. Nelson, J.B. (2003) Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: a randomized, phase II, placebo-controlled trial. Journal of Clinical Oncology, 21, 679 689.
21. Murphy, G. (2005) Atrasentan for metastatic hormone refractory prostate cancer. Issues in Emerging Health Technology, 77, 1 4.
22. Michaelson, M.D., Kaufman, D.S., Kantoff, P., Oh, W.K. Smith, M.R. (2006) Randomized phase II study of atrasentan alone or in combination with zoledronic acid in men with metastatic prostate cancer. Cancer, 107, 530 535.